STILIGE
LIVE

Serial Number

79412899

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Nov 1, 2024

Add to watchlist:

No watchlists yet
View on USPTO

STILIGE Trademark

Serial Number: 79412899 • Registration: 7895547

STILIGE is a trademark filed by NOVARTIS AG on November 1, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,165 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

November 1, 2024

Registration Date

August 19, 2025

Published for Opposition

July 1, 2025

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 18, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 18, 2026 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 18, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 19, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 19, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 1, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 1, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 25, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 2, 2025 CNSA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 30, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 30, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 30, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 30, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 30, 2025 COAR
INTERNATIONAL REGISTRATION RENEWED
May 30, 2025 RNWL
ASSIGNED TO EXAMINER
May 28, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
May 27, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 27, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 31, 2024 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Dec 19, 2024 SDRC